Titre : Sondes d'acide nucléique

Sondes d'acide nucléique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Diffuse
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sondes d'acide nucléique : Questions médicales les plus fréquentes", "headline": "Sondes d'acide nucléique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sondes d'acide nucléique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-17", "dateModified": "2025-05-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sondes d'acide nucléique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sondes moléculaires", "url": "https://questionsmedicales.fr/mesh/D015335", "about": { "@type": "MedicalCondition", "name": "Sondes moléculaires", "code": { "@type": "MedicalCode", "code": "D015335", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Éléments antisens (génétique)", "alternateName": "Antisense Elements (Genetics)", "url": "https://questionsmedicales.fr/mesh/D016375", "about": { "@type": "MedicalCondition", "name": "Éléments antisens (génétique)", "code": { "@type": "MedicalCode", "code": "D016375", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ADN antisens", "alternateName": "DNA, Antisense", "url": "https://questionsmedicales.fr/mesh/D016373", "about": { "@type": "MedicalCondition", "name": "ADN antisens", "code": { "@type": "MedicalCode", "code": "D016373", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.200" } } }, { "@type": "MedicalWebPage", "name": "Oligonucléotides antisens", "alternateName": "Oligonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D016376", "about": { "@type": "MedicalCondition", "name": "Oligonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D016376", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Oligodésoxyribonucléotides antisens", "alternateName": "Oligodeoxyribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020319", "about": { "@type": "MedicalCondition", "name": "Oligodésoxyribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020319", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640.640" } } } ] }, { "@type": "MedicalWebPage", "name": "Oligodésoxyribonucléotides antisens", "alternateName": "Oligodeoxyribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020319", "about": { "@type": "MedicalCondition", "name": "Oligodésoxyribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020319", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640.640" } } }, { "@type": "MedicalWebPage", "name": "ARN antisens", "alternateName": "RNA, Antisense", "url": "https://questionsmedicales.fr/mesh/D016372", "about": { "@type": "MedicalCondition", "name": "ARN antisens", "code": { "@type": "MedicalCode", "code": "D016372", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Oligoribonucléotides antisens", "alternateName": "Oligoribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020320", "about": { "@type": "MedicalCondition", "name": "Oligoribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760.645" } } } ] }, { "@type": "MedicalWebPage", "name": "Oligoribonucléotides antisens", "alternateName": "Oligoribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020320", "about": { "@type": "MedicalCondition", "name": "Oligoribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760.645" } } } ] }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN", "alternateName": "DNA Probes", "url": "https://questionsmedicales.fr/mesh/D015342", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN", "code": { "@type": "MedicalCode", "code": "D015342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ADN complémentaire", "alternateName": "DNA, Complementary", "url": "https://questionsmedicales.fr/mesh/D018076", "about": { "@type": "MedicalCondition", "name": "ADN complémentaire", "code": { "@type": "MedicalCode", "code": "D018076", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.260" } } }, { "@type": "MedicalWebPage", "name": "Amorces ADN", "alternateName": "DNA Primers", "url": "https://questionsmedicales.fr/mesh/D017931", "about": { "@type": "MedicalCondition", "name": "Amorces ADN", "code": { "@type": "MedicalCode", "code": "D017931", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.600" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN spécifiques des gènes HLA", "alternateName": "DNA Probes, HLA", "url": "https://questionsmedicales.fr/mesh/D015343", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN spécifiques des gènes HLA", "code": { "@type": "MedicalCode", "code": "D015343", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.615" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN spécifiques du VPH", "alternateName": "DNA Probes, HPV", "url": "https://questionsmedicales.fr/mesh/D015344", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN spécifiques du VPH", "code": { "@type": "MedicalCode", "code": "D015344", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.620" } } } ] }, { "@type": "MedicalWebPage", "name": "Sondes oligonucléotidiques", "alternateName": "Oligonucleotide Probes", "url": "https://questionsmedicales.fr/mesh/D015345", "about": { "@type": "MedicalCondition", "name": "Sondes oligonucléotidiques", "code": { "@type": "MedicalCode", "code": "D015345", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.650" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ARN", "alternateName": "RNA Probes", "url": "https://questionsmedicales.fr/mesh/D015347", "about": { "@type": "MedicalCondition", "name": "Sondes d'ARN", "code": { "@type": "MedicalCode", "code": "D015347", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.825" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ARN complémentaire", "alternateName": "RNA, Complementary", "url": "https://questionsmedicales.fr/mesh/D018075", "about": { "@type": "MedicalCondition", "name": "ARN complémentaire", "code": { "@type": "MedicalCode", "code": "D018075", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.825.840" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Sondes d'acide nucléique", "alternateName": "Nucleic Acid Probes", "code": { "@type": "MedicalCode", "code": "D015341", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Na Li", "url": "https://questionsmedicales.fr/author/Na%20Li", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China." } }, { "@type": "Person", "name": "Ru Sun", "url": "https://questionsmedicales.fr/author/Ru%20Sun", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China." } }, { "@type": "Person", "name": "Yu-Jie Xu", "url": "https://questionsmedicales.fr/author/Yu-Jie%20Xu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, 215123, Suzhou, China." } }, { "@type": "Person", "name": "Jian-Feng Ge", "url": "https://questionsmedicales.fr/author/Jian-Feng%20Ge", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China. ge_jianfeng@hotmail.com." } }, { "@type": "Person", "name": "Bo Tang", "url": "https://questionsmedicales.fr/author/Bo%20Tang", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis.", "datePublished": "2024-10-31", "url": "https://questionsmedicales.fr/article/39482761", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13075-024-03418-2" } }, { "@type": "ScholarlyArticle", "name": "Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.", "datePublished": "2023-06-15", "url": "https://questionsmedicales.fr/article/37098795", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/art.42510" } }, { "@type": "ScholarlyArticle", "name": "A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis.", "datePublished": "2023-05-15", "url": "https://questionsmedicales.fr/article/36787101", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/art.42477" } }, { "@type": "ScholarlyArticle", "name": "Disturbed Complement Receptor Expression Pattern of B Cells Is Enhanced by Toll-like Receptor CD180 Ligation in Diffuse Cutaneous Systemic Sclerosis.", "datePublished": "2024-08-26", "url": "https://questionsmedicales.fr/article/39273179", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms25179230" } }, { "@type": "ScholarlyArticle", "name": "Purtscher-Like Retinopathy Induced by Diffuse Cutaneous Systemic Scleroderma.", "datePublished": "2023-11-09", "url": "https://questionsmedicales.fr/article/37950491", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/qjmed/hcad255" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Utilisations spécialisées de produits chimiques", "item": "https://questionsmedicales.fr/mesh/D020313" }, { "@type": "ListItem", "position": 4, "name": "Produits chimiques de laboratoire", "item": "https://questionsmedicales.fr/mesh/D019995" }, { "@type": "ListItem", "position": 5, "name": "Sondes moléculaires", "item": "https://questionsmedicales.fr/mesh/D015335" }, { "@type": "ListItem", "position": 6, "name": "Sondes d'acide nucléique", "item": "https://questionsmedicales.fr/mesh/D015341" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sondes d'acide nucléique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sondes d'acide nucléique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sondes d'acide nucléique", "description": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?\nQuelles maladies peuvent être détectées avec des sondes ?\nQuel est le principe de fonctionnement des sondes ?\nLes sondes peuvent-elles détecter des mutations génétiques ?\nQuel type d'échantillons est utilisé pour les sondes ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Diffuse&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique révèlent-elles des symptômes ?\nPeut-on utiliser des sondes pour surveiller des symptômes ?\nLes sondes peuvent-elles aider à prédire des symptômes ?\nLes sondes sont-elles liées à des symptômes spécifiques ?\nComment les sondes aident-elles à comprendre les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Diffuse&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?\nComment les sondes aident-elles à la prévention des maladies ?\nPeut-on utiliser des sondes pour la vaccination ?\nLes sondes peuvent-elles détecter des infections précoces ?\nLes sondes sont-elles utilisées dans les programmes de santé publique ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Diffuse&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?\nComment les sondes influencent-elles le choix du traitement ?\nPeut-on développer des traitements basés sur des sondes ?\nLes sondes aident-elles à surveiller l'efficacité des traitements ?\nLes sondes sont-elles utilisées dans les essais cliniques ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Diffuse&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique peuvent-elles causer des complications ?\nQuelles complications peuvent survenir avec des sondes ?\nLes sondes peuvent-elles entraîner des effets secondaires ?\nComment minimiser les complications liées aux sondes ?\nLes sondes sont-elles fiables pour éviter des complications ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Diffuse&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sondes d'acide nucléique", "description": "Quels facteurs de risque sont associés à l'utilisation des sondes ?\nLes sondes sont-elles influencées par des facteurs environnementaux ?\nL'âge est-il un facteur de risque pour l'utilisation des sondes ?\nLes habitudes de vie influencent-elles les résultats des sondes ?\nLes sondes sont-elles affectées par des facteurs génétiques ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Scleroderma,+Diffuse&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier des séquences génétiques spécifiques liées à des maladies." } }, { "@type": "Question", "name": "Quelles maladies peuvent être détectées avec des sondes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour détecter des infections virales, bactériennes et des cancers." } }, { "@type": "Question", "name": "Quel est le principe de fonctionnement des sondes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles se lient spécifiquement à des séquences cibles, permettant leur détection par hybridation." } }, { "@type": "Question", "name": "Les sondes peuvent-elles détecter des mutations génétiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines sondes sont conçues pour identifier des mutations spécifiques dans l'ADN." } }, { "@type": "Question", "name": "Quel type d'échantillons est utilisé pour les sondes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons de sang, de tissus ou de fluides corporels peuvent être analysés." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique révèlent-elles des symptômes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles détectent des séquences génétiques, pas des symptômes cliniques." } }, { "@type": "Question", "name": "Peut-on utiliser des sondes pour surveiller des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en surveillant des biomarqueurs associés à des symptômes spécifiques." } }, { "@type": "Question", "name": "Les sondes peuvent-elles aider à prédire des symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent indiquer un risque accru de maladies, mais pas de symptômes immédiats." } }, { "@type": "Question", "name": "Les sondes sont-elles liées à des symptômes spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont liées à des maladies, qui peuvent avoir des symptômes variés." } }, { "@type": "Question", "name": "Comment les sondes aident-elles à comprendre les symptômes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à identifier les causes génétiques sous-jacentes des symptômes observés." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en permettant le dépistage précoce de maladies génétiques ou infectieuses." } }, { "@type": "Question", "name": "Comment les sondes aident-elles à la prévention des maladies ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier les individus à risque et de mettre en place des mesures préventives." } }, { "@type": "Question", "name": "Peut-on utiliser des sondes pour la vaccination ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent aider à développer des vaccins en identifiant des cibles immunogènes." } }, { "@type": "Question", "name": "Les sondes peuvent-elles détecter des infections précoces ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont efficaces pour détecter des infections à un stade précoce." } }, { "@type": "Question", "name": "Les sondes sont-elles utilisées dans les programmes de santé publique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont intégrées dans des programmes de dépistage et de surveillance épidémiologique." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont pas des traitements, mais aident à guider les choix thérapeutiques." } }, { "@type": "Question", "name": "Comment les sondes influencent-elles le choix du traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles identifient des cibles spécifiques, permettant des thérapies ciblées adaptées." } }, { "@type": "Question", "name": "Peut-on développer des traitements basés sur des sondes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements peuvent être développés pour cibler des séquences spécifiques." } }, { "@type": "Question", "name": "Les sondes aident-elles à surveiller l'efficacité des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être utilisées pour évaluer la réponse au traitement au niveau moléculaire." } }, { "@type": "Question", "name": "Les sondes sont-elles utilisées dans les essais cliniques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour évaluer des biomarqueurs dans les essais cliniques." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique peuvent-elles causer des complications ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement sûres, mais des erreurs de diagnostic peuvent entraîner des complications." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des sondes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des faux positifs ou négatifs, affectant le traitement." } }, { "@type": "Question", "name": "Les sondes peuvent-elles entraîner des effets secondaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles n'ont pas d'effets secondaires directs, mais des erreurs peuvent avoir des conséquences." } }, { "@type": "Question", "name": "Comment minimiser les complications liées aux sondes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "En utilisant des protocoles de test rigoureux et en validant les résultats obtenus." } }, { "@type": "Question", "name": "Les sondes sont-elles fiables pour éviter des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement fiables, mais leur précision dépend de la qualité des échantillons." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés à l'utilisation des sondes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux de maladies génétiques ou infectieuses." } }, { "@type": "Question", "name": "Les sondes sont-elles influencées par des facteurs environnementaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme l'exposition à des agents pathogènes peuvent influencer les résultats." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour l'utilisation des sondes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies détectées par sondes sont plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles les résultats des sondes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme peuvent affecter la santé et les résultats des tests." } }, { "@type": "Question", "name": "Les sondes sont-elles affectées par des facteurs génétiques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations génétiques peuvent influencer la sensibilité et la spécificité des sondes." } } ] } ] }

Sources (8668 au total)

Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis.

Patients with diffuse cutaneous systemic sclerosis (dcSSc) frequently show spontaneous improvement of skin fibrosis. Our aim was to examine whether an improvement in skin fibrosis predicts lower likel... Patients from the European Scleroderma Trials and Research (EUSTAR) cohort with dcSSc, baseline modified Rodnan skin score (mRSS) ≥7, and valid mRSS at 12±3 months follow up were included. Regression/... Of 1257 included patients, 883 (70.2%) were stable, 282 (22.4%) regressive, and 92 (7.3%) progressive. Regressive patients, adjusted for baseline mRSS, baseline immunosuppression, baseline FVC, and di... We found that regression of skin fibrosis is associated with a lower probability of lung progression and better survival at follow up. The link between the disease course of skin and lung fibrosis in ...

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.

This phase 3 study was undertaken to investigate the efficacy and safety of lenabasum, a cannabinoid type 2 receptor agonist, in patients with diffuse cutaneous systemic sclerosis (dcSSc).... A multinational double-blind study was conducted in 365 dcSSc patients who were randomized and dosed 1:1:1 with lenabasum 20 mg, lenabasum 5 mg, or placebo, each twice daily and added to background tr... The primary end point, the American College of Rheumatology combined response index in dcSSc (CRISS) at week 52 for lenabasum 20 mg twice a day versus placebo, was not met, with CRISS score of 0.888 v... A benefit of lenabasum in dcSSc was not demonstrated. Most patients were treated with background IST, and treatment with mycophenolate mofetil in particular was associated with better outcomes. These ...

A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis.

We undertook this study to explore the efficacy, safety, and tolerability of ziritaxestat, a selective autotaxin inhibitor, in patients with early diffuse cutaneous systemic sclerosis (dcSSc).... NOVESA was a 24-week, multicenter, phase IIa, double-blind, placebo-controlled study. Adults with dcSSc were randomized to oral ziritaxestat 600 mg once daily or matching placebo. The primary efficacy... Patients were randomized to ziritaxestat (n = 21) or placebo (n = 12). Reduction in MRSS was significantly greater in the ziritaxestat group versus the placebo group (-8.9 versus -6.0 units, respectiv... Ziritaxestat resulted in significantly greater reduction in MRSS at week 24 than placebo; no new safety signals emerged. Biomarker analysis suggests ziritaxestat may reduce fibrosis. Modulation of the...

Diffuse Gastrointestinal Motor Compromise in Patients with Scleroderma: Utility of Minimally Invasive Techniques.

Scleroderma is a systemic inflammatory disorder that can compromise the gastrointestinal tract in up to 90% of patients.... The purpose of this work is to characterize esophageal, gastric, and intestinal compromise in patients with scleroderma by means of minimally invasive methods and its association with symptoms and sev... Patients with systemic sclerosis were recruited according to the criteria of the American College of Rheumatology. The study of digestive involvement was carried out on four consecutive days: esophage... A total of 30 patients were included, with an average age of 52.7 years and 93% women. Average disease evolution duration was 6.5 years, 70% with limited variety. Rodnan averaged 12 points, being high... Gastrointestinal involvement in patients with scleroderma is frequent and is observed regardless of the symptoms and clinical characteristics of the latter, except for skin involvement....